BioClinica acquires Synowledge

Wednesday, September 23, 2015

BioClinica, a specialty clinical trials services and technology provider, has acquired Synowledge to expand its offering into the growing drug safety and regulatory business process outsourcing market. Based in Miami, Synowledge specializes in pharmacovigilance, regulatory affairs and information technology services to support biopharmaceutical companies with recording, analyzing and reporting adverse drug events.

[Read More]

BioClinica announces eHealth App xChange

Wednesday, September 9, 2015

BioClinica, a specialty clinical trials technology and services provider, has created the eHealth App xChange, an alliance channel for disruptive technology innovation across life sciences and healthcare. BioClinica’s eHealth App xChange provides healthcare payers, providers, researchers, regulators and patients with access to transformative applications integrated with and delivered through BioClinica’s eHealth Cloud.

[Read More]

BioClinica acquires MediciGroup

Wednesday, July 8, 2015

BioClinica, a specialty clinical trials services and technology provider, has acquired a global patient recruitment and retention firm, MediciGroup (Medici). The acquisition includes affiliates MediciGlobal and Access to Patients. Medici also provides a lost-to-follow-up patient locate service (L2FU) that finds missing patients globally. Together with Medici, BioClinica will offer pharmaceutical companies comprehensive patient recruitment and retention services that improve the speed and efficiency of global clinical trials.

[Read More]

BioClinica expands, opens new European offices

Monday, July 6, 2015

BioClinica, a global specialty clinical trial service provider, has opened new and expanded offices in London and Munich to better serve its growing client base in Europe. The state-of-the-art facilities will offer an array of clinical trial services including medical imaging, site training and support, and eClinical product lines to meet the growing need of European drug and medical device sponsors. BioClinica’s clients include pharmaceutical, biotechnology and medical device companies, as well as CRO partnerships in Europe and across the globe.

[Read More]

Water Street invests in generic injectable drug services company Custopharm

Wednesday, February 4, 2015

Water Street Healthcare Partners, a strategic investor focused exclusively on the healthcare industry headquartered in Chicago, has invested in Custopharm, a generic injectable drug services company. Water Street’s team has committed equity to both acquire and expand the Carlsbad, Calif.-based company. The healthcare firm has recruited William Larkins, Ph.D., former vice president and general manager of Bedford Laboratories, as CEO of Custopharm.

[Read More]